Teladoc Health, Inc.'s (NYSE:TDOC) Recent 8.0% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
Teladoc Health, Inc.'s (NYSE:TDOC) Recent 8.0% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
Key Insights
關鍵洞察
- Significantly high institutional ownership implies Teladoc Health's stock price is sensitive to their trading actions
- The top 16 shareholders own 50% of the company
- Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business
- 顯著高的機構持股意味着Teladoc Health的股票價格對他們的交易行爲敏感。
- 前16大股東持有公司50%的股份。
- 分析師的預測以及持有數據有助於強烈理解業務的前景
Every investor in Teladoc Health, Inc. (NYSE:TDOC) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 69% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
每一個Teladoc Health, Inc.(紐交所:TDOC)的投資者都應該了解最強大的股東群體。我們可以看到,機構在公司中擁有69%的大部分股份。換句話說,這個群體將從對公司的投資中獲得最大利益(或遭受最大損失)。
And institutional investors saw their holdings value drop by 8.0% last week. Needless to say, the recent loss which further adds to the one-year loss to shareholders of 58% might not go down well especially with this category of shareholders. Institutions or "liquidity providers" control large sums of money and therefore, these types of investors usually have a lot of influence over stock price movements. As a result, if the decline continues, institutional investors may be pressured to sell Teladoc Health which might hurt individual investors.
上週,機構投資者看到他們的持股價值下跌了8.0%。 不用說,這一最近的損失進一步加重了股東58%的年度損失,恐怕不會讓這個類別的股東感到愉快。 機構或「流動性提供者」控制着大量資金,因此,這類投資者通常對股票價格的波動有很大影響。 因此,如果下跌持續,機構投資者可能會受到壓力出售Teladoc Health,這可能會對個人投資者造成傷害。
In the chart below, we zoom in on the different ownership groups of Teladoc Health.
在下面的圖表中,我們聚焦於Teladoc Health的不同擁有群體。
What Does The Institutional Ownership Tell Us About Teladoc Health?
機構所有權對Teladoc Health有什麼啓示?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。
Teladoc Health already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Teladoc Health's earnings history below. Of course, the future is what really matters.
Teladoc Health已經在股份登記冊上有機構投資者。實際上,他們擁有公司相當可觀的股份。這表明,該公司在投資界具有一定程度的可信度。然而,最好小心不要過於依賴機構投資者所帶來的所謂驗證。他們有時也會出錯。如果多家機構同時改變對某隻股票的看法,您可能會看到股價快速下跌。因此,查看Teladoc Health的盈利歷史是值得的。當然,未來才是真正重要的。
Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. It would appear that 5.5% of Teladoc Health shares are controlled by hedge funds. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. BlackRock, Inc. is currently the company's largest shareholder with 11% of shares outstanding. With 10% and 5.5% of the shares outstanding respectively, The Vanguard Group, Inc. and Point72 Asset Management, L.P. are the second and third largest shareholders.
機構投資者擁有超過50%的公司股份,因此他們可以強有力地影響董事會決策。看起來5.5%的Teladoc HealtH股票由對沖基金控制。這引起了我的注意,因爲對沖基金有時會試圖影響管理層,或者帶來將爲股東創造短期價值的變革。目前,貝萊德是該公司最大的股東,持有11%的流通股份。先鋒集團公司和Point72資產管理公司分別以10%和5.5%的流通股份成爲第二和第三大股東。
A closer look at our ownership figures suggests that the top 16 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.
仔細查看我們的持股數據,前16位股東的合計持股達到50%,這意味着沒有單一股東擁有多數股份。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.
研究一家公司的機構持有情況可以爲您的研究增加價值,但研究分析師的推薦也是一個好的做法,以更深入地了解股票的預期表現。許多分析師在跟蹤這隻股票,因此也值得看看他們的預測。
Insider Ownership Of Teladoc Health
Teladoc Health的內部人持股情況
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
內部人的定義在不同國家之間可能略有不同,但董事會成員總是算作內部人。公司管理層負責運營業務,但首席執行官將向董事會負責,即使他或她是董事會的成員。
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
當內部持股顯示領導層像真正的公司所有者一樣思考時,這是積極的。然而,高比例的內部持股也可能給予公司內部小團體巨大的權力。在某些情況下,這可能是負面的。
Our information suggests that Teladoc Health, Inc. insiders own under 1% of the company. It's a big company, so even a small proportional interest can create alignment between the board and shareholders. In this case insiders own US$15m worth of shares. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.
我們的信息顯示,Teladoc Health, Inc. 的內部人士持有公司不到1%的股份。 這是大公司,所以即使是小的比例利益也能在董事會和股東之間創建一致性。在這種情況下,內部人士持有價值1500萬美元的股票。看到董事會成員擁有股票是好的,但可能值得檢查一下這些內部人士是否一直在買入。
General Public Ownership
公衆持股
With a 24% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Teladoc Health. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.
擁有24%的股份,公衆一般投資者在Teladoc Health 有一定的影響力。 儘管這部分股份相當可觀,但如果決策與其他大型股東不同,這可能不足以改變公司政策。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Teladoc Health has 2 warning signs we think you should be aware of.
我發現了解誰擁有一家公司非常有趣。但要真正獲得洞察力,我們還需要考慮其他信息。以風險爲例——Teladoc Health有2個我們認爲你應該注意的警告標誌。
If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.
如果您想了解分析師對未來增長的預測,請不要錯過這份關於分析師預測的免費報告。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。